September 11, 2012 - The Canadian Foundation on Fetal Alcohol Research (CFFAR) has announced the recipients of its annual grants Read more »
A National FASD Conference hosted by fasdNL and the FACE Research Association
Register online at: https://www.med.mun.ca/pdcs/program_info.asp?programID=2600
Questions regarding registration, please contact Professional Development & Conferencing Services at (709) 777-6653. All other inquiries, please contact the Conference Planning Committee at (toll free) 1-855-579-9073 or e-mail: email@example.com
Sheraton Hotel, downtown St. Johns, Newfoundland.
Telephone: 1-800-325-3535 or (709) 726-4980
Book online at: www.starwoodmeeting.com/StarGroupsWeb/res?id=1304223705&key=8458
Group rate available until August 3, 2013
Accreditation & Certificate of Attendance
All registered participants will receive a Certificate of Attendance. Presentations on September 6 and 7, 2013 (Fri and Sat) are currently under review for Continuing Medical Education (CME) accreditation for members of the College of Family Physicians of Canada (CFPC) and the Royal College of Physicians and Surgeons of Canada (RCPSC).
Call for Abstracts
We invite poster submissions on all topics of medical and social science research related to Fetal Alcohol Spectrum Disorder for the annual FACE Poster Competition. The deadline for submitting poster abstracts is August 29, 2013.
Please visit the Guidelines section to learn more »»
A Novel Neuropsychological Screening Test for FASD
Dr. Gideon Koren, Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, Ontario
Based on the Child Behavior Checklist, Motherisk has validated a neurobehavioral tool that has high sensitivity and specificity for Fetal Alcohol Spectrum Disorder. This tool has been recently accepted as a screening tool by the Public Health Agency of Canada.
Meconium Fatty Acit Ethyl Esters as Biomarkers of Ethanol Exposure in Late Gestation and Indicators of Ethanol-induced Multi-organ Injury in Fetal Sheep
Irene Zelner 1,2; Kelly Kenna 3; James F. Brien 4; Alan Bocking,5; Richard Harding 3; David Walker 6; Gideon Koren 1,2 1 Division of Clinical Pharmacology & Toxicology, The Hospital for Sick Children, Toronto, ON, Canada; 2 Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada; 3 Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia; 4 Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada; 5 Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON, Canada; 6 Ritchie Centre for Infant Health, Monash Institute of Medical Research, Monash University, Clayton, VIC
Previously, meconium concentrations of fatty acid ethyl esters (FAEE) have been shown to be specific and sensitive biomarkers of heavy fetal exposure to ethanol. To the best of our knowledge, the present study is the first report evaluating the utility of meconium concentrations in identifying fetuses with organ-system injury resulting from in-utero ethanol exposure. In an ovine model, we found that meconium FAEE concentration was a highly sensitive and specific biomarker of a relatively moderate-dose fetal ethanol exposure in late gestation, and could be used to identify fetuses with ethanol-induced toxic effects in numerous organs, including the kidney, lungs, heart, and brain. This demonstrates the potential for using meconium FAEE to identify neonates at risk for major organ dysfunction following in-utero ethanol exposure that does not result in overt malformations. These findings add to the existing body of literature on the sensitivity, specificity, and potential clinical utility of meconium testing for FAEE as a screen for identifying newborns at risk for fetal alcohol spectrum disorders.
Early Results of Evidence-Based Educational Remediation in Motherisk School Program for Children with FASD
Gal Koren, Motherisk FASD Clinic Follow-Up Coordinator
After several years of advocacy, in 2012 the Motherisk Program began an ambitious program providing treatment support and academic remediation programming for children in Toronto with confirmed Fetal Alcohol Spectrum Disorders. In its inaugural year the program, named Transitions, has delivered two full-time day school classrooms for 'high-risk' students aged seven to nine. In 2013 the program will be expanding to serve students from grades one through to six. The presentation by program developer and coordinator, Gal Koren, will highlight some of the promising evidence-based practices the program utilizes, and share some preliminary short-term student and program outcomes.
* - "MOTHERISK - Treating the mother - Protecting the unborn" is an official mark of The Hospital for Sick Children. All rights reserved.
The information on this website is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and before you take any medications.
Copyright © 1999-2013 The Hospital for Sick Children (SickKids). All rights reserved.
The Hospital for Sick Children (SickKids) is a health-care, teaching and research centre dedicated exclusively to children; affiliated with the University of Toronto. For general inquires please call: 416-813-1500.